EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer
Imfinzi, in combination with etoposide and either carboplatin or cisplatin, is also approved in the US, Japan and several other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ES-SCLC
Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India
Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…